Showing 1–50 of 159 results

2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,144.00 – $7,500.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$600.00 – $5,000.00
Western Blot of Adalimumab Biosimilar ICH40012020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$300.00 – $5,000.00
+
 Quick View

anti-human

Blinatumomab Biosimilar – Research Grade [ICH5025]

$300.00 – $4,000.00
Western Blot of Atezolizumab Biosimilar ICH4018
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$718.00 – $5,000.00
2020 FDA Approvals for Trastuzumab
+
 Quick View

anti-human

Trastuzumab Biosimilar – Research Grade [ICH4013]

$718.00 – $5,000.00
+
 Quick View

anti-human

Theralizumab Biosimilar – Research Grade [ICH5023]

$300.00 – $5,000.00
Western Blot of Pembrolizumab Biosimilar ICH40292020 FDA Approvals for Pembrolizumab
+
 Quick View

anti-human

Pembrolizumab Biosimilar – Research Grade [ICH4029]

$718.00 – $5,000.00
2020 FDA Approvals for Rituximab
+
 Quick View

anti-human

Rituximab Biosimilar – Research Grade [ICH4011]

$718.00 – $5,000.00
2020 FDA Approvals for Ranibizumab
+
 Quick View

anti-human

Ranibizumab Biosimilar – Research Grade [ICH4031]

$718.00 – $4,161.00
2020 FDA Approvals Ipilimumab
+
 Quick View

anti-human

Ipilimumab Biosimilar – Research Grade [ICH4025]

$718.00 – $5,000.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$718.00 – $5,000.00
Natalizumab biosimilar
+
 Quick View

anti-human

Natalizumab Biosimilar – Research Grade [ICH4037]

$300.00 – $5,000.00
+
 Quick View

anti-human

Etanercept Biosimilar – Research Grade [ICH4022]

$718.00 – $5,000.00
2020 FDA Approvals for Pertuzumab
+
 Quick View

anti-human

Pertuzumab Biosimilar – Research Grade [ICH4030]

$718.00 – $5,000.00
+
 Quick View

anti-human

Bulk anti-Human MHC Class I antibody (W6/32) [ICH1023]

$375.00 – $2,450.00
+
 Quick View

anti-human

Monalizumab Biosimilar – Research Grade [ICH5017]

$300.00 – $5,000.00
2020 FDA Approvals for Ustekinumab
+
 Quick View

anti-human

Ustekinumab Biosimilar – Research Grade [ICH4034]

$718.00 – $5,000.00
2020 FDA Approvals for Secukinumab
+
 Quick View

anti-human

Secukinumab Biosimilar – Research Grade [ICH4033]

$300.00 – $5,000.00
+
 Quick View

anti-human

Panitumumab Biosimilar – Research Grade [ICH4028]

$718.00 – $5,000.00
2020 FDA Approvals Eculizumab
+
 Quick View

anti-human

Eculizumab Biosimilar – Research Grade [ICH4005]

$300.00 – $5,000.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$718.00 – $5,000.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$718.00 – $5,000.00
+
 Quick View

anti-human

Urelumab Biosimilar – Research Grade [ICH5015]

$300.00 – $5,000.00
2020 FDA Approvals for Ofatumumab
+
 Quick View

anti-human

Ofatumumab Biosimilar – Research Grade [ICH4027]

$718.00 – $5,000.00
2020 FDA Approvals for Nivolumab
+
 Quick View

anti-human

Nivolumab Biosimilar – Research Grade [ICH4009]

$718.00 – $5,000.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$718.00 – $5,000.00
Western Blot of Avelumab Biosimilar ICH40172020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$718.00 – $5,000.00
+
 Quick View

anti-bovine

Bulk anti-human TGF-B1,2,3 antibody (1D11.1) [ICH1090]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD14 antibody (UCHM-1) [ICH1009]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD3 antibody (UCHT-1) [ICH1002]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD16 antibody (3G8) [ICH1010]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD19 antibody (SJ25-C1) [ICH1011]

$375.00 – $2,450.00
Western Blot of Infliximab Biosimilar ICH40062020 FDA Approvals Infliximab
+
 Quick View

anti-human

Infliximab Biosimilar – Research Grade [ICH4006]

$300.00 – $5,000.00
+
 Quick View

anti-human

Mosunetuzumab Biosimilar – Research Grade [ICH5026]

$350.00 – $9,000.00
+
 Quick View

anti-human

Varlilumab Biosimilar – Research Grade [ICH5022]

$300.00 – $5,000.00
+
 Quick View

anti-human

Glofitamab Biosimilar – Research Grade [ICH5019]

$350.00 – $9,000.00
2020 FDA Approvals for Obinutuzumab
+
 Quick View

anti-human

Obinutuzumab Biosimilar – Research Grade [ICH4026]

$718.00 – $5,000.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$718.00 – $15,000.00
+
 Quick View

anti-human

Bulk anti-Human HLA-DQ antibody (1a3)

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human HLA-DR antibody (L243) [ICH1026]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human HLA-DP antibody (B7/21) [ICH1024]

$375.00 – $2,950.00
+
 Quick View

anti-human

Bulk anti-Human CD56 antibody (ERIC-1) [ICH1015]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD71 antibody (T56/14) [ICH1018]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD11b antibody (ICRF44) [ICH1007]

$375.00 – $2,450.00
+
 Quick View

anti-human

Bulk anti-Human CD8 antibody (UCHT-4) [ICH1005]

$375.00 – $2,450.00
+
 Quick View

anti-human

Mogamulizumab Biosimilar – Research Grade: HRP

$350.00
+
 Quick View

anti-human

Utomilumab Biosimilar – Research Grade [ICH5014]

$300.00 – $5,000.00
+
 Quick View

anti-human

Sutimlimab Biosimilar – Research Grade [ICH5012]

$300.00 – $5,000.00
+
 Quick View

anti-human

Aducanumab Biosimilar – Research Grade [ICH5008]

$300.00 – $5,000.00